Maite Alvarez (Maite Álvarez)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 27

Top Venues

Journal for immunotherapy of cancer

Blood

Science advances

British journal of cancer

University of Navarra

University of California Davis School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Navarra Feb 15 2018

Spain

Marie Curie Action Research Fellow :: Immunology and Immunotherapy

Stanford University School of Medicine Jan 27 2013 - Jan 31 2018

United States

Post-doctoral Research Fellow :: Bone and Marrow Transplantation Division

University of California Davis School of Medicine Jan 01 2009 - Jan 26 2013

United States

Graduate Student :: Dermatology

Univesity of Nevada, Reno Aug 29 2007 - Dec 31 2008

United States

Visitor Scholar :: Microbiology and Immunology

Education History

University of California Davis School of Medicine Jan 01 2009 - Dec 14 2012

United States

PHD :: Dermatology

Universidad del Pais Vasco Jul 01 2005 - Jun 30 2007

Spain

MSC :: Genetics

Universidad del Pais Vasco Sep 26 2000 - Jun 30 2005

Spain

BSC

Publications

Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Ignacio Melero, Carmen Molina, Cristina Eguizabal, Maite Alvarez
Intratumoral NK cell delivery combined with neutralization of the NKG2A pathway as treatment for solid cancer. Genes and immunity (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Javier Glez-Vaz, Arantza Azpilikueta, María Carmen Ochoa, Irene Olivera, Gabriel Gomis, Assunta Cirella, Carlos Luri-Rey, Maite Alvarez, Jose-Luis Perez-Gracia, Sergio Ciordia, Iñaki Eguren, Raluca Alexandru, Pedro Berraondo, Carlos E De Andrea, Alvaro Teijeira, Fernando Corrales, Juan M Zapata, Ignacio Melero Bermejo
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects. Science advances 9 (33) (2023)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Ignacio Melero Bermejo, Maria C Ochoa, Carmen Molina, Sandra Sanchez-Gregorio, Saray Garasa, Carlos Luri-Rey, Sandra Hervas-Stubbs, Noelia Casares, Edurne Elizalde, Gabriel Gomis, Assunta Cirella, Pedro Berraondo, Alvaro Teijeira, Maite Alvarez
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies. EMBO molecular medicine (2023)
Maite Alvarez, Carmen Molina, Saray Garasa, Maria C Ochoa, Maria E Rodriguez-Ruiz, Gabriel Gomis, Assunta Cirella, Irene Olivera, Javier Glez-Vaz, Jose Gonzalez-Gomariz, Carlos Luri-Rey, Arantza Azpilikueta, Elixabet Bolaños, Alvaro Teijeira, Pedro Berraondo, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic. Oncoimmunology 12 (1) (2023)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Ángela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, Jose Gonzalez-Gomariz, Celia Gomar, Joan Salvador Russo-Cabrera, Irene Olivera, Assunta Cirella, Myriam Fernandez-Sendin, Maite Alvarez, Alvaro Teijeira, Cigdem Atay, José Medina-Echeverz, Maria Hinterberger, Hubertus Hochrein, Ignacio Melero Bermejo, Pedro Berraondo, Fernando Aranda
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis. Journal for immunotherapy of cancer 11 (11) (2023)
Javier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, Assunta Cirella, Alvaro Teijeira, Maria C Ochoa, Maite Alvarez, Iñaki Eguren, Carlos Luri-Rey, Maria E Rodriguez-Ruiz, Xinxin Nie, Lieping Chen, Sonia Guedan, Miguel F Sanamed, Jose Luis Perez Gracia, Ignacio Melero Bermejo
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. Journal for immunotherapy of cancer 10 (3) (2022)
Irene Olivera, Vicente Martín, Elixabet Bolaños, Inmaculada Rodriguez, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Saray Garasa, Itziar Migueliz, Iñaki Eguren, Miguel F Sanmamed, Javier Glez-Vaz, Arantza Azpilikueta, Maite Alvarez, María Carmen Ochoa, Beatrice Malacrida, David J Propper, Carlos E De Andrea, Pedro Berraondo, Frances R Balkwill, Alvaro Teijeira, Ignacio Melero Bermejo
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β. Cancer discovery 12 (9) (2022)
Shirley Tenesaca, Marcos Vasquez, Maite Alvarez, Itziar Otano, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Nuria Ardaiz, Celia Gomar, Angela Bella, Fernando Aranda, José Medina-Echeverz, Ignacio Melero Bermejo, Pedro Berraondo
Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors. Journal for immunotherapy of cancer 9 (7) (2022)
Alberto Mendoza-Valderrey, Maite Alvarez, Andrea De Maria, Kim A Margolin, Ignacio Melero, Maria Libera Ascierto
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity. Cells 11 (19) (2022)
Federico Simonetta, Juliane K Lohmeyer, Toshihito Hirai, Kristina Maas-Bauer, Maite Alvarez, Arielle S Wenokur, Jeanette Baker, Amin Aalipour, Xuhuai Ji, Samuel Haile, Crystal L Mackall, Robert S Negrin
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Kristina Maas-Bauer, Juliane K Lohmeyer, Toshihito Hirai, Teresa Lopes Ramos, Furqan M Fazal, Ulrike M Litzenburger, Kathryn E Yost, Jessica V Ribado, Neeraja Kambham, Arielle S Wenokur, Po-Yu Lin, Maite Alvarez, Melissa Mavers, Jeanette Baker, Ami Siddharth Bhatt, Howard Y Chang, Federico Simonetta, Robert S Negrin
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects. Blood 138 (10) (2021)
Maite Alvarez, Carmen Molina, Carlos E De Andrea, Myriam Fernandez-Sendin, Maria Villalba, Jose Gonzalez-Gomariz, Maria Carmen Ochoa, Alvaro Teijeira, Javier Glez-Vaz, Fernando Aranda, Miguel F Sanmamed, Maria E Rodriguez-Ruiz, Xinyi Fan, Wen H Shen, Pedro Berraondo, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy. Journal for immunotherapy of cancer 9 (11) (2021)
Ethan G Aguilar, Cordelia Dunai, Sean J Judge, Anthony E Zamora, Lam T Khuat, Logan V Vick, Craig P Collins, Kevin M Stoffel, Maite Alvarez, Isabel Barao, Jeffrey S Miller, Bruce R Blazar, Patrice Chevallier, Christelle Retiere, Robert J Canter, William J Murphy
Activation status dictates the function of unlicensed natural killer cells in mice and humans. Blood advances 5 (20) (2021)
Ignacio Melero Bermejo, Eduardo Castanon, Maite Alvarez, Stephane Champiat, Aurélien Marabelle
Intratumoural administration and tumour tissue targeting of cancer immunotherapies. Nature reviews. Clinical oncology 18 (9) (2021)
Itziar Otano, Arantza Azpilikueta, Javier Glez-Vaz, Maite Alvarez, José Medina-Echeverz, Ivan Cortés-Domínguez, Carlos Ortiz de Solórzano, Peter Ellmark, Sara Fritzell, Gabriela Hernandez-Hoyos, Michelle Hase Nelson, María Carmen Ochoa, Elixabet Bolaños, Doina Cuculescu, Patricia Jaúregui, Sandra Sanchez-Gregorio, Iñaki Etxeberría, María E Rodriguez-Ruiz, Miguel F Sanmamed, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero Bermejo
CD137 (4-1BB) costimulation of CD8 + T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation. Nature communications 12 (1) (2021)
Sara Zalba, Virginia Belsúe, Brian Topp, Dinesh de Alwis, Maite Alvarez, Iñaki F Trocóniz, Pedro Berraondo, María J Garrido
Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1. British journal of cancer 124 (7) (2021)
Maite Alvarez, Cordelia Dunai, Lam T Khuat, Ethan G Aguilar, Isabel Barao, William J Murphy
IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation. Cancers 12 (11) (2020)
Maite Alvarez, Kai Sun, William J Murphy
Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment. Blood 127 (9) (2016)

Maite Alvarez.css-eqlu8i{font-size:small;padding-left:4px;} (Maite Álvarez)

Publication Activity (10 Years)

Top Topics

Top Venues

Maite Alvarez (Maite Álvarez)